Cannabis
Life Sciences

Focusing on Cultivation, Production and Dispensaries

At CLS Holdings, we have developed a "seed to sale" acquisition strategy that involves acquiring cannabis dispensaries, cultivators and producers. We started with the booming Nevada market, one of the fastest-growing markets in the U.S., and have a definitive agreement to enter Massachusetts by the end of 2019, as well as a robust pipeline in other Western states.

CLS stands for "Cannabis Life Sciences," in recognition of our patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. CLS Holdings has recently received a Notice of Allowance from the U.S. Patent Office for its proprietary extraction and conversion methodology.

About Us
High Quality,  Craft Cannabis

High Quality, Craft Cannabis

At CLS we believe in a quality-first approach. We have spent tireless hours to ensure our standards are upheld at our Oasis Cannabis dispensary and our seed to sale brand, City Trees. Our management team along with our world-class employees have put practices in place that drive efficiencies and profitability all while maintaining consistent quality of products across the board. Like most, we are in the people business and we believe we have the best people in the business.

Our Process
71%

YOY increase in consolidated net revenue

108%

YOY increase of City Trees net revenue

53%

YOY increase of Oasis net revenue

61%

YOY increase in customer orders

Our Brands